SE405966B - Sett att framstella peptider - Google Patents
Sett att framstella peptiderInfo
- Publication number
- SE405966B SE405966B SE7303498A SE7303498A SE405966B SE 405966 B SE405966 B SE 405966B SE 7303498 A SE7303498 A SE 7303498A SE 7303498 A SE7303498 A SE 7303498A SE 405966 B SE405966 B SE 405966B
- Authority
- SE
- Sweden
- Prior art keywords
- peptims
- produce
- way
- produce peptims
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
- C07K1/084—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP47026467A JPS5025442B2 (sv) | 1972-03-14 | 1972-03-14 | |
JP2874072A JPS5725540B2 (sv) | 1972-03-21 | 1972-03-21 | |
JP2874172A JPS5647175B2 (sv) | 1972-03-21 | 1972-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE405966B true SE405966B (sv) | 1979-01-15 |
Family
ID=27285414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7303498A SE405966B (sv) | 1972-03-14 | 1973-03-13 | Sett att framstella peptider |
Country Status (10)
Country | Link |
---|---|
US (1) | US3870694A (sv) |
AU (1) | AU466760B2 (sv) |
CA (1) | CA998997A (sv) |
CH (1) | CH581097A5 (sv) |
DK (1) | DK129088B (sv) |
FR (1) | FR2176009B1 (sv) |
GB (1) | GB1374379A (sv) |
HU (1) | HU170340B (sv) |
NL (1) | NL175522C (sv) |
SE (1) | SE405966B (sv) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4126628A (en) * | 1977-03-28 | 1978-11-21 | Canadian Patents And Development Limited | Acylation of amino acids |
US4581168A (en) * | 1983-02-21 | 1986-04-08 | Sanofi | Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides |
GB2144128B (en) * | 1983-07-29 | 1986-11-26 | Sanyo Machine Works | The tripeptide eisenin and carcinostatic compositions having an immunopotentiating carcinostatic effect which contain it |
US5502165A (en) * | 1994-04-04 | 1996-03-26 | Merck & Co., Inc. | Process for peptide segment condensation |
US6120491A (en) * | 1997-11-07 | 2000-09-19 | The State University Rutgers | Biodegradable, anionic polymers derived from the amino acid L-tyrosine |
AU761458B2 (en) | 1998-04-13 | 2003-06-05 | Rutgers, The State University | The construction of copolymer libraries |
US7521061B2 (en) * | 1999-12-31 | 2009-04-21 | Rutgers, The State University Of New Jersey | Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
BRPI0713153B8 (pt) * | 2006-06-13 | 2021-05-25 | Helix Biomedix Inc | tetrapeptídeo capaz de induzir a produção das proteínas da matriz extracelular e composição o compreendendo |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1593842A1 (de) * | 1967-01-05 | 1970-08-27 | Hoechst Ag | Verfahren zur Herstellung von Peptiden |
-
1973
- 1973-03-08 AU AU53087/73A patent/AU466760B2/en not_active Expired
- 1973-03-09 DK DK129173AA patent/DK129088B/da unknown
- 1973-03-13 US US340893A patent/US3870694A/en not_active Expired - Lifetime
- 1973-03-13 HU HUTA1239A patent/HU170340B/hu unknown
- 1973-03-13 FR FR7308948A patent/FR2176009B1/fr not_active Expired
- 1973-03-13 CA CA166,028A patent/CA998997A/en not_active Expired
- 1973-03-13 SE SE7303498A patent/SE405966B/sv unknown
- 1973-03-14 CH CH372073A patent/CH581097A5/xx not_active IP Right Cessation
- 1973-03-14 NL NLAANVRAGE7303589,A patent/NL175522C/xx not_active IP Right Cessation
- 1973-03-14 GB GB1222473A patent/GB1374379A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK129088B (da) | 1974-08-19 |
CH581097A5 (sv) | 1976-10-29 |
FR2176009B1 (sv) | 1977-08-12 |
FR2176009A1 (sv) | 1973-10-26 |
NL175522B (nl) | 1984-06-18 |
HU170340B (sv) | 1977-05-28 |
US3870694A (en) | 1975-03-11 |
NL175522C (nl) | 1984-11-16 |
AU466760B2 (en) | 1975-11-06 |
CA998997A (en) | 1976-10-26 |
NL7303589A (sv) | 1973-09-18 |
GB1374379A (en) | 1974-11-20 |
AU5308773A (en) | 1974-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE406554B (sv) | Sett att framstella mikropartiklar | |
SE415182B (sv) | Sett att framstella platinakoordinationsforeningar | |
SE7614680L (sv) | Sett att framstella nya bensodiazepinderivat | |
SE411349B (sv) | Sett att framstella nya penicilliner | |
SE417982B (sv) | Sett att framstella cefalosporinforeningar | |
SE417089B (sv) | Sett att framstella en sulfonamidoarylforening | |
SE8205332D0 (sv) | Sett att framstella hoghallfast stalband | |
SE382215B (sv) | Sett att framstella kromanderivat | |
SE391181B (sv) | Sett att framstella kinazolinderivat | |
SE399255B (sv) | Sett att framstella kinazolinonderivat | |
SE7603277L (sv) | Sett att framstella prostansyraderivat | |
SE417211B (sv) | Sett att framstella indenyl-3-acetoglucuronider | |
SE417981B (sv) | Sett att framstella cefalosporinforeningar | |
SE381651B (sv) | Sett att framstella karbamater | |
SE386164B (sv) | Sett att framstella nya 2-alkylamino-dihydropyridiner | |
SE405966B (sv) | Sett att framstella peptider | |
SE399270B (sv) | Sett att framstella spirolaktonsteroider | |
SE381257B (sv) | Sett att framstella rifamycinderivat | |
SE400078B (sv) | Sett att framstella kinazolinonderivat | |
SE397679B (sv) | Sett att framstella kinazolinonderivat | |
SE381831B (sv) | Sett att tillverka kylare | |
SE399712B (sv) | Sett att framstella pregnansyraderivat | |
SE392204B (sv) | Sett att framstella jordnotsmjol | |
SE400281B (sv) | Sett att framstella kinazolinonderivat | |
SE389443B (sv) | Sett att framstella en fergad fodoemneskomposition |